Exhibit 99.1
eHealth, Inc. Announces Fourth Quarter and Fiscal 2009 Results
Fourth Quarter 2009 Overview
| | • | | Revenue of $34.4 million, up 17% over the fourth quarter of 2008 |
| | • | | Operating income of $6.9 million, up 22% over the fourth quarter of 2008 |
| | • | | Growth in IFP submitted applications of 6% over the fourth quarter of 2008 |
| | • | | GAAP operating margins of 20% and non-GAAP operating margins of 24% for the fourth quarter of 2009 |
| | • | | GAAP net income of $4.8 million, or $0.20 per diluted share, and non-GAAP net income of $5.1 million, or $0.21 per diluted share, for the fourth quarter of 2009 |
| | • | | Cash flow from operations of $9.4 million, up 26% from the fourth quarter of 2008 |
MOUNTAIN VIEW, Calif.—February 11, 2010—eHealth, Inc. (NASDAQ: EHTH), the leading online source of health insurance for individuals, families and small businesses, today announced its financial results for the fourth quarter ended December 31, 2009.
Gary Lauer, chief executive officer of eHealth stated, “Fourth quarter results represented a nice ending to a year in which we grew our revenues by 21%, operating income by 22%, generated over $30 million in operating cash flow and completed a $30 million share repurchase program. That was all accomplished in the face of an uncertain economic environment and an unpredictable healthcare reform legislative process. During the fourth quarter, we grew revenue at a healthy rate, expanded operating margins, further diversified our business and announced our plans to launch into the seniors market.”
Fourth Quarter Results
Revenue—Revenue totaled $34.4 million for the fourth quarter of 2009, a 17% increase compared to revenue of $29.5 million for the fourth quarter of 2008.
Submitted Applications—Submitted applications for individual and family products increased 6% in the fourth quarter of 2009 to 122,300 applications, compared to 115,600 applications in the fourth quarter of 2008.
Membership—Estimated membership at December 31, 2009 totaled 728,000 members, a 17% increase over estimated membership of 621,100 at December 31, 2008.
Operating Income—Operating income increased 22% to $6.9 million for the fourth quarter of 2009, compared to operating income of $5.7 million for the fourth quarter of 2008. Operating margins were 20% and 19% in the fourth quarters of 2009 and 2008, respectively. Non-GAAP operating income increased 27% to $8.3 million for the fourth quarter of 2009, compared to non-GAAP operating income of $6.5 million for the fourth quarter of 2008. Non-GAAP operating margins were 24% and 22% in the fourth quarters of 2009 and 2008, respectively. Non-GAAP operating income and margins in the fourth quarters of 2009 and 2008 exclude $1.4 million and $0.9 million of stock-based compensation expense, respectively.
Pre-tax Income—Pre-tax income for the fourth quarter of 2009 was $7.0 million, a 12% increase compared to pre-tax income of $6.3 million for the fourth quarter of 2008. Pre-tax income was unfavorably impacted in the fourth quarter of 2009 by a decrease in interest income of $0.5 million compared to the fourth quarter of 2008.
Net Income—Net income for the fourth quarter of 2009 was $4.8 million, or $0.20 per diluted share. Net income for the fourth quarter of 2008 was $3.6 million, or $0.14 per diluted share. Non-GAAP net income for the fourth quarter of 2009 was $5.1 million, or $0.21 per diluted share, compared to non-GAAP net income for the fourth quarter of 2008 of $4.2 million, or $0.16 per diluted share. Non-GAAP net income and non-GAAP net income per diluted share in the fourth quarter of 2009 exclude $1.4 million of stock-based compensation expense, less $0.5 million for related income tax benefit and $0.6 million of discrete income tax benefit related to an increase in deferred income tax assets resulting from a reduction in estimated limitations on both federal and California net operating loss carryforwards. Non-GAAP net income and non-GAAP net income per diluted share in the fourth quarter of 2008 exclude $0.9 million of stock-based compensation expense, less $0.4 million for related income tax benefit.
Cash Flow and Cash Balance—Cash flow from operations for the fourth quarter of 2009 was $9.4 million, compared to $7.4 million for the fourth quarter of 2008, representing an increase of 26%.
The fourth quarter 2009 cash flow statement includes a $4.3 million cash flow benefit from deferred income taxes, of which $3.3 million primarily relates to the utilization of net operating loss carryforwards and $1.0 million relates to the utilization of excess tax benefits related to share-based payments. The fourth quarter 2008 cash flow statement included a $2.3 million cash flow benefit from deferred income taxes, of which $2.2 million primarily relates to the utilization of net operating loss carryforwards and $0.1 million relates to the utilization of excess tax benefits related to share-based payments. The utilization of excess tax benefits related to share-based payments is also shown in the cash flow statement for the fourth quarters of 2008 and 2009 as a decrease in cash flow from operating activities and an increase in cash flow from financing activities.
Cash, cash equivalents and short-term marketable securities as of December 31, 2009 totaled $153.5 million, compared to $150.6 million as of December 31, 2008.
During the fourth quarter of 2008, eHealth’s board of directors authorized a stock repurchase program of up to $30 million, or ten percent of eHealth’s outstanding common stock, whichever is less. Repurchases pursuant to the program began in December 2008 and were completed in the third quarter of 2009. As of December 31, 2009, 1.9 million shares of common stock had been repurchased in connection with the stock repurchase program at an average price of $15.97 per share, including commissions, for a total cost of $30 million, of which approximately 1.8 million shares were repurchased during 2009 for a total cost of $29.4 million.
Fiscal 2009 Results
Revenue—Revenue totaled $134.9 million for the year ended December 31, 2009, a 21% increase compared to revenue of $111.7 million for the year ended December 31, 2008.
Operating Income—Operating income increased 22% to $25.8 million for the year ended December 31, 2009, compared to operating income of $21.3 million for the year ended December 31, 2008. Operating margins were 19% in both years ended December 31, 2009 and 2008.
Pre-tax Income—Pre-tax income for the year ended December 31, 2009 was $26.8 million, a 7% increase compared to pre-tax income of $25.0 million for the year ended December 31, 2008. Pre-tax income was unfavorably impacted in the year ended December 31, 2009 by a decrease in interest income of $2.8 million compared to the year ended December 31, 2008.
Net Income—Net income for the year ended December 31, 2009 was $15.3 million, or $0.61 per diluted share, compared to net income for the year ended December 31, 2008 of $14.2 million, or $0.55 per diluted share.
Cash Flow—Cash flow from operations for the year ended December 31, 2009 was $30.1 million, compared to $30.2 million for the year ended December 31, 2008.
2010 Guidance
eHealth is providing guidance for the full year ending December 31, 2010 based on information currently available:
| | • | | Total revenue is expected to be in the range of $148 million to $155 million |
| | • | | Stock-based compensation expense is expected to be in the range of $6 million to $7.5 million |
| | • | | GAAP income tax rate is expected to be in the range of 43% to 45% |
| | • | | GAAP net income per diluted share is expected to be in the range of $0.55 to $0.65 per share |
“I would like to provide some additional comments on our 2010 guidance,” said Stuart Huizinga, chief financial officer of eHealth. “We expect to invest just over $3 million to support our Medicare initiative in 2010, which we expect will impact our GAAP net income per diluted share for 2010 by approximately $0.08.”
Webcast and Conference Call Information
A Webcast and conference call will be held today, Thursday, February 11, 2010 at 5:00 p.m. EST / 2:00 p.m. PST. The Webcast will be available live on the Investor Relations section on eHealth’s website athttp://ir.ehealthinsurance.com. Individuals interested in listening to the conference call may do so by dialing 866-730-5764 for domestic callers and 857-350-1588 for international callers. The participant passcode is #68051978. A telephone replay will be available two hours following the conclusion of the call for a period of 30 days and can be accessed by dialing 888-286-8010 for domestic callers and 617-801-6888 for international callers. The call ID for the replay is #16823489. The live and archived webcast of the call will also be available on eHealth’s website athttp://www.ehealthinsurance.comunder the Investor Relations section.
About eHealth, Inc.
eHealth, Inc. is the parent company of eHealthInsurance, the leading online source of health insurance for individuals, families and small businesses. eHealthInsurance presents complex health insurance information in an objective, user-friendly format, enabling the research, analysis, comparison and purchase of health insurance products that best meet consumers’ needs. eHealth and eHealthInsurance are registered trademarks of eHealthInsurance Services, Inc.
eHealth, Inc. was founded in 1997 and its technology was responsible for the nation’s first Internet-based sale of a health insurance policy. eHealth is headquartered in Mountain View, California. Additional information can be found on eHealth’s website,http://www.ehealthinsurance.com.
Forward-Looking Statements
This press release contains statements that are forward-looking statements as defined within the Private Securities Litigation Reform Act of 1995. These include statements regarding eHealth’s plans with respect to Medicare and the seniors market; investment in eHealth’s Medicare initiative in 2010 and related net income per diluted share impact; and eHealth’s guidance for total revenue, stock-based compensation expense, GAAP income tax rate, and GAAP net income per diluted share for the year ending December 31, 2010. These forward-looking statements are inherently subject to various risks and uncertainties that could cause actual results to differ materially from the statements made, including risks associated with changes and developments in the structure of the health insurance system in the United States and healthcare system reform, eHealth’s rate of growth, changes in the economy, weak economic conditions, consumer awareness of the availability and accessibility of affordable health insurance, eHealth’s success in marketing Medicare-related health insurance products, changes in member conversion rates and factors affecting conversion, eHealth’s ability to continue to increase its membership base and retain its members, eHealth’s ability to maintain or expand its relationships with health insurance carriers and marketing partners, negative publicity experienced by eHealth’s carrier partners, changes in products offered on eHealth’s ecommerce platform, changes in commission payments or carrier underwriting practices, maintaining and enhancing eHealth’s brand identity and the effectiveness of eHealth’s marketing and public relations efforts, system failures, capacity constraints, data loss or online commerce security risks, continued acceptance of the Internet as a medium for the purchase and sale of health insurance, dependence upon Internet search engines, reliance on marketing partners and factors affecting submitted applications from the marketing partner channel, the pursuit of new strategies and opportunities in the health insurance market, timing of receipt and accuracy of commission reports and related impact on estimating membership, payment practices of health insurance carriers, competition, eHealth’s operations in China and any expansion into foreign countries, success in the sale of sponsorship advertising and the licensing of the use of eHealth’s ecommerce platform, protection of intellectual property and defense of intellectual property rights claims, legal liability, regulatory penalties and negative publicity, ability to attract and retain qualified personnel, management of future growth, seasonality, impact of future acquisitions, implementation of internal enterprise systems and maintenance of proper and effective internal controls, impact of provisions for income taxes, changes in laws and regulations, compliance with insurance and other laws and regulations, exposure to online commerce security risks, and the performance, reliability and availability of eHealth’s ecommerce platform and underlying network infrastructure. Other factors that could cause operating, financial and other results to differ are described in eHealth’s most recent Quarterly Report on Form 10-Q or Annual Report on Form 10-K filed with the Securities and Exchange Commission and available on the investor relations page of eHealth’s website athttp://www.ehealthinsurance.com and on the Securities and Exchange Commission’s website atwww.sec.gov. eHealth does not undertake any obligation to update any forward-looking statement to conform the statement to actual results or changes in expectations.
Non-GAAP Financial Information
This press release includes financial measures that are not in accordance with generally accepted accounting principles in the United States (“GAAP”). To supplement eHealth’s condensed consolidated financial statements presented in accordance with GAAP, eHealth presents investors with certain non-GAAP financial measures, including non-GAAP operating income, non-GAAP operating margins, non-GAAP pre-tax income, non-GAAP net income and non-GAAP net income per diluted share.
| | • | | Non-GAAP operating income consists of GAAP operating income excluding the effects of expensing stock-based compensation related to stock options, restricted stock and restricted stock units in accordance with FASB ASC Topic 718 beginning in 2006 and amortization of deferred stock-based compensation expense in accordance with APB 25 for grants made prior to 2006. |
| | • | | Non-GAAP operating margins are calculated by dividing non-GAAP operating income by GAAP total revenue. |
| | • | | Non-GAAP net income for the three months and year ended December 31, 2009 consists of GAAP net income excluding stock-based compensation expense recorded during the period (less related income tax benefit) and discrete income tax benefit recorded during the period related to an increase in our deferred income tax assets resulting from a reduction in estimated limitations on both our federal and California net operating loss carryforwards. Non-GAAP net income for the three months and year ended December 31, 2008 consists of GAAP net income excluding stock-based compensation expense recorded during the period (less related income tax benefit). |
| | • | | Non-GAAP net income per diluted share is calculated by dividing non-GAAP net income by GAAP weighted average diluted shares outstanding. |
eHealth believes that the presentation of these non-GAAP financial measures provide important supplemental information to management and investors regarding financial and business trends relating to the company’s financial condition and results of operations. Management believes that the use of these non-GAAP financial measures provides consistency and comparability with the company’s past financial reports. Management also believes that the exclusion of the items described above provides an additional measure of the company’s operating results and facilitates comparisons of the company’s core operating performance against prior periods and business model objectives. This information is provided to investors in order to facilitate additional analyses of past, present and future operating performance and as a supplemental means to evaluate the company’s ongoing operations. Externally, the company believes that these non-GAAP financial measures continue to be useful to investors in their assessment of the company’s operating performance.
Non-GAAP operating income, non-GAAP operating margins, non-GAAP net income and non-GAAP net income per diluted share are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures used in this press release have limitations in that they do not reflect all of the costs associated with the operations of the company’s business and do not reflect all of the income tax as determined in accordance with GAAP. As a result, you should not consider these measures in isolation or as a substitute for analysis of eHealth’s results as reported under GAAP. The company expects to continue to incur stock-based compensation costs described above, and exclusion of these costs, and their related income tax impact, from non-GAAP financial measures should not be construed as an inference that these costs are unusual or infrequent. The company compensates for these limitations by prominently disclosing GAAP operating income, GAAP net income and GAAP net income per diluted share and providing investors with reconciliations from the company’s GAAP operating results to the non-GAAP financial measures for the relevant periods.
The accompanying tables provide more details on the GAAP financial measures that are most directly comparable to the non-GAAP financial measures and the related reconciliations between these financial measures.
Investor Relations Contact:
Kate Sidorovich
Director, Investor Relations
440 East Middlefield Road
Mountain View, CA 94043
(650) 210-3111
kate.sidorovich@ehealth.com
http://ir.ehealthinsurance.com
Media Contact:
Brian Mast
Director, Public Relations
440 East Middlefield Road
Mountain View, CA 94043
(650) 210-3149
brian.mast@ehealth.com
http://www.ehealthinsurance.com
(Tables to Follow)
# # #
EHEALTH, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
| | | | | | | | |
| | | December 31,
2008 | | | December 31,
2009 | |
| | | (1) | | | (unaudited) | |
| Assets | | | | | | | | |
Current assets: | | | | | | | | |
Cash and cash equivalents | | $ | 94,136 | | | $ | 131,339 | |
Marketable securities | | | 56,499 | | | | 22,184 | |
Accounts receivable | | | 2,005 | | | | 2,295 | |
Deferred income taxes | | | 7,580 | | | | 6,009 | |
Prepaid expenses and other current assets | | | 1,874 | | | | 2,324 | |
| | | | | | | | |
Total current assets | | | 162,094 | | | | 164,151 | |
Property and equipment, net | | | 4,567 | | | | 3,775 | |
Deferred income taxes | | | 1,314 | | | | 919 | |
Other assets | | | 780 | | | | 863 | |
| | | | | | | | |
Total assets | | $ | 168,755 | | | $ | 169,708 | |
| | | | | | | | |
| | |
| Liabilities and stockholders’ equity | | | | | | | | |
Current liabilities: | | | | | | | | |
Accounts payable | | $ | 2,190 | | | $ | 3,252 | |
Accrued compensation and benefits | | | 4,662 | | | | 5,051 | |
Accrued marketing expenses | | | 3,162 | | | | 3,879 | |
Deferred revenue | | | 427 | | | | 401 | |
Other current liabilities | | | 2,707 | | | | 2,677 | |
| | | | | | | | |
Total current liabilities | | | 13,148 | | | | 15,260 | |
Other non-current liabilities | | | 628 | | | | 2,997 | |
| | |
Stockholders’ equity: | | | | | | | | |
Common stock | | | 25 | | | | 25 | |
Additional paid-in capital | | | 173,095 | | | | 183,747 | |
Treasury stock shares, at cost | | | (639 | ) | | | (29,999 | ) |
Deferred stock-based compensation | | | (22 | ) | | | — | |
Accumulated deficit | | | (17,892 | ) | | | (2,545 | ) |
Accumulated other comprehensive income | | | 412 | | | | 223 | |
| | | | | | | | |
Total stockholders’ equity | | | 154,979 | | | | 151,451 | |
| | | | | | | | |
Total liabilities and stockholders’ equity | | $ | 168,755 | | | $ | 169,708 | |
| | | | | | | | |
| (1) | The condensed consolidated balance sheet at December 31, 2008 has been derived from the audited consolidated financial statements at that date. |
EHEALTH, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts)
| | | | | | | | | | | | |
| | | Three Months Ended
December 31, | | Year Ended
December 31, |
| | | 2008 | | 2009 | | 2008 | | 2009 |
| | | (unaudited) | | (unaudited) | | (2) | | (unaudited) |
Revenue: | | | | | | | | | | | | |
Commission | | $ | 26,176 | | $ | 30,030 | | $ | 100,839 | | $ | 119,259 |
Sponsorship, licensing and other | | | 3,279 | | | 4,381 | | | 10,872 | | | 15,631 |
| | | | | | | | | | | | |
Total revenue | | | 29,455 | | | 34,411 | | | 111,711 | | | 134,890 |
Operating costs and expenses: | | | | | | | | | | | | |
Cost of revenue-sharing | | | 408 | | | 993 | | | 1,746 | | | 4,581 |
Marketing and advertising (1) | | | 11,528 | | | 13,356 | | | 42,161 | | | 53,987 |
Customer care and enrollment (1) | | | 3,724 | | | 3,669 | | | 14,379 | | | 14,769 |
Technology and content (1) | | | 3,634 | | | 4,146 | | | 14,182 | | | 15,685 |
General and administrative (1) | | | 4,508 | | | 5,357 | | | 17,983 | | | 20,028 |
| | | | | | | | | | | | |
Total operating costs and expenses | | | 23,802 | | | 27,521 | | | 90,451 | | | 109,050 |
| | | | | | | | | | | | |
Income from operations | | | 5,653 | | | 6,890 | | | 21,260 | | | 25,840 |
Interest and other income, net | | | 629 | | | 138 | | | 3,714 | | | 938 |
| | | | | | | | | | | | |
Income before income taxes | | | 6,282 | | | 7,028 | | | 24,974 | | | 26,778 |
Provision for income taxes | | | 2,633 | | | 2,270 | | | 10,806 | | | 11,431 |
| | | | | | | | | | | | |
Net income | | $ | 3,649 | | $ | 4,758 | | $ | 14,168 | | $ | 15,347 |
| | | | | | | | | | | | |
| | | | |
Net income per share: | | | | | | | | | | | | |
Basic | | $ | 0.15 | | $ | 0.20 | | $ | 0.57 | | $ | 0.63 |
Diluted | | $ | 0.14 | | $ | 0.20 | | $ | 0.55 | | $ | 0.61 |
| | | | |
Weighted-average number of shares used in per share amounts: | | | | | | | | | | | | |
Basic | | | 25,076 | | | 23,380 | | | 24,963 | | | 24,309 |
Diluted | | | 25,826 | | | 24,196 | | | 25,954 | | | 25,201 |
| | | | |
(1) Includes stock-based compensation expense as follows: | | | | | | | | | | | | |
Marketing and advertising | | $ | 160 | | $ | 223 | | $ | 644 | | $ | 803 |
Customer care and enrollment | | | 66 | | | 85 | | | 266 | | | 325 |
Technology and content | | | 245 | | | 380 | | | 898 | | | 1,194 |
General and administrative | | | 414 | | | 719 | | | 1,686 | | | 2,513 |
| | | | | | | | | | | | |
Total | | $ | 885 | | $ | 1,407 | | $ | 3,494 | | $ | 4,835 |
| | | | | | | | | | | | |
| (2) | The condensed consolidated statement of operations for the year ended December 31, 2008 has been derived from the audited consolidated financial statements for that year. |
EHEALTH, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
| | | | | | | | | | | | | | | | |
| | | Three Months Ended
December 31, | | | Year Ended
December 31, | |
| | | 2008 | | | 2009 | | | 2008 | | | 2009 | |
| | | (unaudited) | | | (unaudited) | | | (1) | | | (unaudited) | |
Operating activities | | | | | | | | | | | | | | | | |
Net income | | $ | 3,649 | | | $ | 4,758 | | | $ | 14,168 | | | $ | 15,347 | |
Adjustments to reconcile net income to net cash provided by operating activities: | | | | | | | | | | | | | | | | |
Deferred income taxes | | | 2,305 | | | | 4,278 | | | | 9,451 | | | | 9,352 | |
Depreciation and amortization | | | 591 | | | | 538 | | | | 1,863 | | | | 2,211 | |
Amortization and accretion on marketable securities, net | | | — | | | | 142 | | | | — | | | | 749 | |
Stock-based compensation expense | | | 885 | | | | 1,407 | | | | 3,494 | | | | 4,835 | |
Excess tax benefits from stock-based compensation | | | (82 | ) | | | (993 | ) | | | (298 | ) | | | (4,979 | ) |
Deferred rent | | | (8 | ) | | | 12 | | | | (51 | ) | | | (45 | ) |
Loss on disposal of property and equipment | | | 7 | | | | — | | | | 45 | | | | 16 | |
Changes in operating assets and liabilities: | | | | | | | | | | | | | | | | |
Accounts receivable | | | (445 | ) | | | (91 | ) | | | (705 | ) | | | (290 | ) |
Prepaid expenses and other current assets | | | (392 | ) | | | 3 | | | | 64 | | | | 389 | |
Other assets | | | 175 | | | | (115 | ) | | | 196 | | | | 358 | |
Accounts payable | | | 336 | | | | 1,688 | | | | 693 | | | | 1,060 | |
Accrued compensation and benefits | | | 659 | | | | 69 | | | | (41 | ) | | | 388 | |
Accrued marketing expenses | | | (780 | ) | | | (360 | ) | | | 708 | | | | 717 | |
Deferred revenue | | | 76 | | | | 70 | | | | (9 | ) | | | (26 | ) |
Other current liabilities | | | 468 | | | | (2,002 | ) | | | 616 | | | | 4 | |
| | | | | | | | | | | | | | | | |
Net cash provided by operating activities | | | 7,444 | | | | 9,404 | | | | 30,194 | | | | 30,086 | |
| | | | | | | | | | | | | | | | |
| | | | |
Investing activities | | | | | | | | | | | | | | | | |
Purchases of property and equipment | | | (240 | ) | | | (311 | ) | | | (2,482 | ) | | | (1,433 | ) |
Purchase of other assets | | | — | | | | — | | | | — | | | | (1,280 | ) |
Purchases of marketable securities | | | (24,088 | ) | | | — | | | | (85,653 | ) | | | (40,550 | ) |
Sales of marketable securities | | | — | | | | 1,000 | | | | 10,120 | | | | 5,006 | |
Maturities of marketable securities | | | 20,930 | | | | 20,032 | | | | 59,309 | | | | 68,932 | |
| | | | | | | | | | | | | | | | |
Net cash provided by (used in) investing activities | | | (3,398 | ) | | | 20,721 | | | | (18,706 | ) | | | 30,675 | |
| | | | | | | | | | | | | | | | |
| | | | |
Financing activities | | | | | | | | | | | | | | | | |
Net proceeds from exercise of common stock options | | | 121 | | | | 215 | | | | 1,547 | | | | 860 | |
Excess tax benefits from stock-based compensation | | | 82 | | | | 993 | | | | 298 | | | | 4,979 | |
Repurchase of common stock | | | (639 | ) | | | — | | | | (639 | ) | | | (29,360 | ) |
Principal payments in connection with capital lease | | | — | | | | (11 | ) | | | — | | | | (41 | ) |
| | | | | | | | | | | | | | | | |
Net cash provided by (used in) financing activities | | | (436 | ) | | | 1,197 | | | | 1,206 | | | | (23,562 | ) |
| | | | | | | | | | | | | | | | |
Effect of exchange rate changes on cash and cash equivalents | | | 1 | | | | 2 | | | | 47 | | | | 4 | |
| | | | | | | | | | | | | | | | |
Net increase in cash and cash equivalents | | | 3,611 | | | | 31,324 | | | | 12,741 | | | | 37,203 | |
Cash and cash equivalents at beginning of period | | | 90,525 | | | | 100,015 | | | | 81,395 | | | | 94,136 | |
| | | | | | | | | | | | | | | | |
Cash and cash equivalents at end of period | | $ | 94,136 | | | $ | 131,339 | | | $ | 94,136 | | | $ | 131,339 | |
| | | | | | | | | | | | | | | | |
| (1) | The condensed consolidated statement of cash flows for the year ended December 31, 2008 has been derived from the audited consolidated financial statements for that year. |
EHEALTH, INC.
SUMMARY OF SELECTED METRICS
(Unaudited)
| | | | | | | | |
Key Metrics: | | Three Months Ended
December 31, 2008 | | | Three Months Ended
December 31, 2009 | |
Operating cash flows (1) | | $ | 7,444,000 | | | $ | 9,404,000 | |
| | |
IFP submitted applications (2) | | | 115,600 | | | | 122,300 | |
| | |
IFP approved members (3) | | | 97,700 | | | | 96,100 | |
Total approved members (4) | | | 131,200 | | | | 124,400 | |
| | |
Total revenue (5) | | $ | 29,455,000 | | | $ | 34,411,000 | |
Total revenue per estimated member for the period (6) | | $ | 48.16 | | | $ | 47.31 | |
| | |
| | | As of
December 31, 2008 | | | As of
December 31, 2009 | |
IFP estimated membership (7) | | | 528,500 | | | | 636,200 | |
Total estimated membership (8) | | | 621,100 | | | | 728,000 | |
| | |
| | | Three Months Ended
December 31, 2008 | | | Three Months Ended
December 31, 2009 | |
Marketing and advertising expenses (9) | | $ | 11,528,000 | | | $ | 13,356,000 | |
Marketing and advertising expenses as a percentage of total revenue (10) | | | 39 | % | | | 39 | % |
| | |
Marketing and advertising expenses excluding stock-based compensation (11) | | $ | 11,368,000 | | | $ | 13,133,000 | |
Marketing and advertising expenses excluding stock based compensation as a percentage of total revenue (12) | | | 39 | % | | | 38 | % |
| | |
Other Metrics: | | | | | | | | |
| | |
Source of IFP submitted applications (as a percentage of total IFP applications for the period): | | | | | | | | |
Direct (13) | | | 40 | % | | | 44 | % |
Marketing partners (14) | | | 32 | % | | | 29 | % |
Online advertising (15) | | | 28 | % | | | 27 | % |
| | | | | | | | |
Total | | | 100 | % | | | 100 | % |
| | | | | | | | |
Acquisition cost per individual on IFP submitted applications (16) | | $ | 65.35 | | | $ | 73.38 | |
Acquisition cost (excluding stock-based compensation) per individual on IFP submitted applications (17) | | $ | 64.44 | | | $ | 72.16 | |
Notes:
| (1) | Net cash provided by operating activities for the period from the condensed consolidated statements of cash flows. |
| (2) | IFP applications submitted on eHealth’s website during the period. Applications are counted as submitted when the applicant completes the application, provides a method for payment and clicks the submit button on our website and submits the application to us. The applicant generally has additional actions to take before the application will be reviewed by the insurance carrier, such as providing additional information and providing an electronic signature. In addition, an applicant may submit more than one application. We include applications for IFP products for which we receive commissions as well as other forms of payment. We define our “IFP” offerings as major medical individual and family health insurance plans, which does not include small business, short-term major medical, stand-alone dental, life or student health insurance product offerings. |
| (3) | New IFP members reported to eHealth as approved during the period. Some members that are approved by a carrier do not accept the approval and therefore do not become paying members. Does not include members transferred from Health Benefits Direct Corporation. |
| (4) | New members for all products reported to eHealth as approved during the period. Some members that are approved by a carrier do not accept the approval and therefore do not become paying members. Does not include members transferred from Health Benefits Direct Corporation. |
| (5) | Total revenue (from all sources) recognized during the period from the condensed consolidated statements of income. |
| (6) | Calculated as total revenue recognized during the period (see note (5) above) divided by average estimated membership for the period (calculated as beginning and ending estimated membership for all products for the period, divided by two). Ending membership includes an estimated 20,000 of members transferred from Health Benefits Direct Corporation during 2009, net of estimated cancelations since their transfer.See our Form 10-Q for the quarterly period ended September 30, 2009 - Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations – Summary of Selected Metrics for additional information regarding our calculation of estimated membership. |
| | |
| (7) | | Estimated number of members active on IFP insurance policies as of the date indicated. Amounts as of December 31, 2009 include an estimated 20,000 members transferred from Health Benefits Direct Corporation during 2009, net of estimated cancelations since their transfer. See ourForm 10-Q for the quarterly period ended September 30, 2009 - Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations – Summary of Selected Metrics for additional information regarding our calculation of estimated membership. |
| (8) | | Estimated number of members active on all insurance policies as of the date indicated. Amounts as of December 31, 2009 include an estimated 20,000 of members transferred from Health Benefits Direct Corporation during 2009, net of estimated cancelations since their transfer. See ourForm 10-Q for the quarterly period ended September 30, 2009 - Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations – Summary of Selected Metrics for additional information regarding our calculation of estimated membership. |
| (9) | | Marketing and advertising expenses for the period from the condensed consolidated statements of income. |
| (10) | | Calculated as marketing and advertising expenses for the period (see note (9) above) divided by total revenue for the period (see note (5) above). |
| (11) | | Non-GAAP marketing and advertising expenses excluding stock-based compensation for the period. SeeNon-GAAP Financial Information above and the reconciliation of GAAP to Non-GAAP marketing and advertising expenses below. |
| (12) | | Calculated as non-GAAP marketing and advertising expenses for the period (see note (11) above) divided by total revenue for the period (see note (5) above). SeeNon-GAAP Financial Information above and the reconciliation of GAAP to Non-GAAP marketing and advertising expenses below. |
| (13) | | Percentage of IFP submitted applications from applicants who came directly to the eHealth website through algorithmic search engine results or otherwise. See note (2) above for further information as to what constitutes a submitted application. |
| (14) | | Percentage of IFP submitted applications from applicants sourced through eHealth’s network of marketing partners. See note (2) above for further information as to what constitutes a submitted application. |
| (15) | | Percentage of IFP submitted applications from applicants sourced through paid search and other online advertising activities. See note (2) above for further information as to what constitutes a submitted application. |
| (16) | | Calculated as marketing and advertising expenses for the period (see note (9) above) divided by the number of individuals on IFP applications submitted on eHealth’s website during the period. This metric may not reflect the true acquisition cost. |
| (17) | | Calculated as non-GAAP marketing and advertising expenses for the period (see note (11) above) divided by the number of individuals on IFP applications submitted on eHealth’s website during the period. This metric may not reflect the true acquisition cost exclusive of the impact of stock-based compensation allocated to marketing and advertising expenses. |
EHEALTH, INC.
GAAP TO NON-GAAP RECONCILIATION
FOR THE THREE MONTHS ENDED DECEMBER 31, 2009
(In thousands, except per share amounts, unaudited)
Statement of Income Reconciliation
| | | | | | | | | | | | | | | | |
| | | Three Months Ended December 31, 2009 | |
| | | GAAP
Reported | | GAAP
Percent of
Total
Revenue | | | Adjustments | | | Non-GAAP
Results | | Non-GAAP
Percent of
Total
Revenue | |
Revenue: | | | | | | | | | | | | | | | | |
Commission | | $ | 30,030 | | 87 | % | | $ | — | | | $ | 30,030 | | 87 | % |
Sponsorship, licensing and other | | | 4,381 | | 13 | | | | — | | | | 4,381 | | 13 | |
| | | | | | | | | | | | | | | | |
Total revenue | | | 34,411 | | 100 | | | | — | | | | 34,411 | | 100 | |
Operating costs and expenses: | | | | | | | | | | | | | | | | |
Cost of revenue-sharing | | | 993 | | 3 | | | | — | | | | 993 | | 3 | |
Marketing and advertising (1) | | | 13,356 | | 39 | | | | (223 | ) | | | 13,133 | | 38 | |
Customer care and enrollment (1) | | | 3,669 | | 11 | �� | | | (85 | ) | | | 3,584 | | 10 | |
Technology and content (1) | | | 4,146 | | 12 | | | | (380 | ) | | | 3,766 | | 11 | |
General and administrative (1) | | | 5,357 | | 16 | | | | (719 | ) | | | 4,638 | | 13 | |
| | | | | | | | | | | | | | | | |
Total operating costs and expenses | | | 27,521 | | 80 | | | | (1,407 | ) | | | 26,114 | | 76 | |
| | | | | | | | | | | | | | | | |
Income from operations | | | 6,890 | | 20 | | | | 1,407 | | | | 8,297 | | 24 | |
Interest and other income, net | | | 138 | | 0 | | | | — | | | | 138 | | 0 | |
| | | | | | | | | | | | | | | | |
Income before income taxes | | | 7,028 | | 20 | | | | 1,407 | | | | 8,435 | | 25 | |
Provision for income taxes (2) | | | 2,270 | | 7 | | | | 1,064 | | | | 3,334 | | 10 | |
| | | | | | | | | | | | | | | | |
Net income (3) | | $ | 4,758 | | 14 | % | | $ | 343 | | | $ | 5,101 | | 15 | % |
| | | | | | | | | | | | | | | | |
| | | | | |
Net income per share: (3) | | | | | | | | | | | | | | | | |
Basic | | $ | 0.20 | | | | | $ | 0.02 | | | $ | 0.22 | | | |
Diluted | | $ | 0.20 | | | | | $ | 0.01 | | | $ | 0.21 | | | |
| | | | | |
Weighted-average number of shares used in per share amounts: | | | | | | | | | | | | | | | | |
Basic | | | 23,380 | | | | | | 23,380 | | | | 23,380 | | | |
Diluted | | | 24,196 | | | | | | 24,196 | | | | 24,196 | | | |
Explanation of adjustments
| | |
| (1) | | Non-GAAP results exclude the effect of expensing stock-based compensation related to stock options, restricted stock and restricted stock units in accordance with FASB ASC Topic 718 beginning in 2006, in addition to the amortization of deferred stock-based compensation expense in accordance with APB 25 for grants made prior to 2006. |
| (2) | | Provision for income taxes excludes estimated income tax benefit of $479,000 related to stock-based compensation expense listed in note (1) above, as well as income tax benefit of $585,000 related to an increase in deferred income tax assets resulting from a reduction in estimated limitations on both federal and California net operating loss carryforwards. |
| (3) | | Non-GAAP net income and non-GAAP net income per share exclude stock-based compensation expense listed in note (1) above and estimated income tax benefits listed in note (2) above. |
EHEALTH, INC.
GAAP TO NON-GAAP RECONCILIATION
FOR THE THREE MONTHS ENDED DECEMBER 31, 2008
(In thousands, except per share amounts, unaudited)
Statement of Income Reconciliation
| | | | | | | | | | | | | | | | |
| | | Three Months Ended December 31, 2008 | |
| | | GAAP
Reported | | GAAP
Percent of
Total
Revenue | | | Adjustments | | | Non-GAAP
Results | | Non-GAAP
Percent of
Total
Revenue | |
Revenue: | | | | | | | | | | | | | | | | |
Commission | | $ | 26,176 | | 89 | % | | $ | — | | | $ | 26,176 | | 89 | % |
Sponsorship, licensing and other | | | 3,279 | | 11 | | | | — | | | | 3,279 | | 11 | |
| | | | | | | | | | | | | | | | |
Total revenue | | | 29,455 | | 100 | | | | — | | | | 29,455 | | 100 | |
Operating costs and expenses: | | | | | | | | | | | | | | | | |
Cost of revenue-sharing | | | 408 | | 1 | | | | — | | | | 408 | | 1 | |
Marketing and advertising (1) | | | 11,528 | | 39 | | | | (160 | ) | | | 11,368 | | 39 | |
Customer care and enrollment (1) | | | 3,724 | | 13 | | | | (66 | ) | | | 3,658 | | 12 | |
Technology and content (1) | | | 3,634 | | 12 | | | | (245 | ) | | | 3,389 | | 12 | |
General and administrative (1) | | | 4,508 | | 15 | | | | (414 | ) | | | 4,094 | | 14 | |
| | | | | | | | | | | | | | | | |
Total operating costs and expenses | | | 23,802 | | 81 | | | | (885 | ) | | | 22,917 | | 78 | |
| | | | | | | | | | | | | | | | |
Income from operations | | | 5,653 | | 19 | | | | 885 | | | | 6,538 | | 22 | |
Interest and other income, net | | | 629 | | 2 | | | | — | | | | 629 | | 2 | |
| | | | | | | | | | | | | | | | |
Income before income taxes | | | 6,282 | | 21 | | | | 885 | | | | 7,167 | | 24 | |
Provision for income taxes (2) | | | 2,633 | | 9 | | | | 355 | | | | 2,988 | | 10 | |
| | | | | | | | | | | | | | | | |
Net income (3) | | $ | 3,649 | | 12 | % | | $ | 530 | | | $ | 4,179 | | 14 | % |
| | | | | | | | | | | | | | | | |
| | | | | |
Net income per share: (3) | | | | | | | | | | | | | | | | |
Basic | | $ | 0.15 | | | | | $ | 0.02 | | | $ | 0.17 | | | |
Diluted | | $ | 0.14 | | | | | $ | 0.02 | | | $ | 0.16 | | | |
| | | | | |
Weighted-average number of shares used in per share amounts: | | | | | | | | | | | | | | | | |
Basic | | | 25,076 | | | | | | 25,076 | | | | 25,076 | | | |
Diluted | | | 25,826 | | | | | | 25,826 | | | | 25,826 | | | |
Explanation of adjustments
| | |
| (1) | | Non-GAAP results exclude the effect of expensing stock-based compensation related to stock options, restricted stock and restricted stock units in accordance with FASB ASC Topic 718 beginning in 2006, in addition to the amortization of deferred stock-based compensation expense in accordance with APB 25 for grants made prior to 2006. |
| (2) | | Provision for income taxes excludes estimated income tax benefit of $355,000 related to stock-based compensation expense listed in note (1) above. |
| (3) | | Non-GAAP net income and non-GAAP net income per share exclude stock-based compensation expense listed in note (1) above and estimated income tax benefit listed in note (2) above. |
EHEALTH, INC.
GAAP TO NON-GAAP RECONCILIATION
FOR THE YEAR ENDED DECEMBER 31, 2009
(In thousands, except per share amounts, unaudited)
Statement of Income Reconciliation
| | | | | | | | | | | | | | | | |
| | | Year Ended December 31, 2009 | |
| | | GAAP
Reported | | GAAP
Percent of
Total
Revenue | | | Adjustments | | | Non-GAAP
Results | | Non-GAAP
Percent of
Total
Revenue | |
Revenue: | | | | | | | | | | | | | | | | |
Commission | | $ | 119,259 | | 88 | % | | $ | — | | | $ | 119,259 | | 88 | % |
Sponsorship, licensing and other | | | 15,631 | | 12 | | | | — | | | | 15,631 | | 12 | |
| | | | | | | | | | | | | | | | |
Total revenue | | | 134,890 | | 100 | | | | — | | | | 134,890 | | 100 | |
Operating costs and expenses: | | | | | | | | | | | | | | | | |
Cost of revenue-sharing | | | 4,581 | | 3 | | | | — | | | | 4,581 | | 2 | |
Marketing and advertising (1) | | | 53,987 | | 40 | | | | (803 | ) | | | 53,184 | | 39 | |
Customer care and enrollment (1) | | | 14,769 | | 11 | | | | (325 | ) | | | 14,444 | | 11 | |
Technology and content (1) | | | 15,685 | | 12 | | | | (1,194 | ) | | | 14,491 | | 11 | |
General and administrative (1) | | | 20,028 | | 15 | | | | (2,513 | ) | | | 17,515 | | 13 | |
| | | | | | | | | | | | | | | | |
Total operating costs and expenses | | | 109,050 | | 81 | | | | (4,835 | ) | | | 104,215 | | 77 | |
| | | | | | | | | | | | | | | | |
Income from operations | | | 25,840 | | 19 | | | | 4,835 | | | | 30,675 | | 23 | |
Interest and other income, net | | | 938 | | 1 | | | | — | | | | 938 | | 1 | |
| | | | | | | | | | | | | | | | |
Income before income taxes | | | 26,778 | | 20 | | | | 4,835 | | | | 31,613 | | 23 | |
Provision for income taxes (2) | | | 11,431 | | 8 | | | | 2,017 | | | | 13,448 | | 10 | |
| | | | | | | | | | | | | | | | |
Net income (3) | | $ | 15,347 | | 11 | % | | $ | 2,818 | | | $ | 18,165 | | 13 | % |
| | | | | | | | | | | | | | | | |
| | | | | |
Net income per share: (3) | | | | | | | | | | | | | | | | |
Basic | | $ | 0.63 | | | | | $ | 0.12 | | | $ | 0.75 | | | |
Diluted | | $ | 0.61 | | | | | $ | 0.11 | | | $ | 0.72 | | | |
| | | | | |
Weighted-average number of shares used in per share amounts: | | | | | | | | | | | | | | | | |
Basic | | | 24,309 | | | | | | 24,309 | | | | 24,309 | | | |
Diluted | | | 25,201 | | | | | | 25,201 | | | | 25,201 | | | |
Explanation of adjustments
| | |
| (1) | | Non-GAAP results exclude the effect of expensing stock-based compensation related to stock options, restricted stock and restricted stock units in accordance with FASB ASC Topic 718 beginning in 2006, in addition to the amortization of deferred stock-based compensation expense in accordance with APB 25 for grants made prior to 2006. |
| (2) | | Provision for income taxes excludes estimated income tax benefit of $1,432,000 related to stock-based compensation expense listed in note (1) above, as well as income tax benefit of $585,000 related to an increase in deferred income tax assets resulting from a reduction in estimated limitations on both federal and California net operating loss carryforwards. |
| (3) | | Non-GAAP net income and non-GAAP net income per share exclude stock-based compensation expense listed in note (1) above and estimated income tax benefits listed in note (2) above. |
EHEALTH, INC.
GAAP TO NON-GAAP RECONCILIATION
FOR THE YEAR ENDED DECEMBER 31, 2008
(In thousands, except per share amounts, unaudited)
Statement of Income Reconciliation
| | | | | | | | | | | | | | | | |
| | | Year Ended December 31, 2008 | |
| | | GAAP
Reported | | GAAP
Percent of
Total
Revenue | | | Adjustments | | | Non-GAAP
Results | | Non-GAAP
Percent of
Total
Revenue | |
Revenue: | | | | | | | | | | | | | | | | |
Commission | | $ | 100,839 | | 90 | % | | $ | — | | | $ | 100,839 | | 90 | % |
Sponsorship, licensing and other | | | 10,872 | | 10 | | | | — | | | | 10,872 | | 10 | |
| | | | | | | | | | | | | | | | |
Total revenue | | | 111,711 | | 100 | | | | — | | | | 111,711 | | 100 | |
Operating costs and expenses: | | | | | | | | | | | | | | | | |
Cost of revenue-sharing | | | 1,746 | | 2 | | | | — | | | | 1,746 | | 2 | |
Marketing and advertising (1) | | | 42,161 | | 38 | | | | (644 | ) | | | 41,517 | | 37 | |
Customer care and enrollment (1) | | | 14,379 | | 13 | | | | (266 | ) | | | 14,113 | | 13 | |
Technology and content (1) | | | 14,182 | | 13 | | | | (898 | ) | | | 13,284 | | 12 | |
General and administrative (1) | | | 17,983 | | 16 | | | | (1,686 | ) | | | 16,297 | | 15 | |
| | | | | | | | | | | | | | | | |
Total operating costs and expenses | | | 90,451 | | 81 | | | | (3,494 | ) | | | 86,957 | | 78 | |
| | | | | | | | | | | | | | | | |
Income from operations | | | 21,260 | | 19 | | | | 3,494 | | | | 24,754 | | 22 | |
Interest and other income, net | | | 3,714 | | 3 | | | | — | | | | 3,714 | | 3 | |
| | | | | | | | | | | | | | | | |
Income before income taxes | | | 24,974 | | 22 | | | | 3,494 | | | | 28,468 | | 25 | |
Provision for income taxes (2) | | | 10,806 | | 9 | | | | 1,142 | | | | 11,948 | | 10 | |
| | | | | | | | | | | | | | | | |
Net income (3) | | $ | 14,168 | | 13 | % | | $ | 2,352 | | | $ | 16,520 | | 15 | % |
| | | | | | | | | | | | | | | | |
| | | | | |
Net income per share: (3) | | | | | | | | | | | | | | | | |
Basic | | $ | 0.57 | | | | | $ | 0.09 | | | $ | 0.66 | | | |
Diluted | | $ | 0.55 | | | | | $ | 0.09 | | | $ | 0.64 | | | |
| | | | | |
Weighted-average number of shares used in per share amounts: | | | | | | | | | | | | | | | | |
Basic | | | 24,963 | | | | | | 24,963 | | | | 24,963 | | | |
Diluted | | | 25,954 | | | | | | 25,954 | | | | 25,954 | | | |
Explanation of adjustments
| | |
| (1) | | Non-GAAP results exclude the effect of expensing stock-based compensation related to stock options, restricted stock and restricted stock units in accordance with FASB ASC Topic 718 beginning in 2006, in addition to the amortization of deferred stock-based compensation expense in accordance with APB 25 for grants made prior to 2006. |
| (2) | | Provision for income taxes excludes estimated income tax benefit of $1,142,000 related to stock-based compensation expense listed in note (1) above. |
| (3) | | Non-GAAP net income and non-GAAP net income per share exclude stock-based compensation expense listed in note (1) above and estimated income tax benefit listed in note (2) above. |
